EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of Lung Cancer Screening, Smoking Cessation, and Cessation Smartphone App to Health-Related Quality of Life Among Heavy Smokers: Randomized Controlled Trial

Antti Kurtti, Sanna Iivanainen, Riitta Kaarteenaho, Heidi Andersen, Antti Jekunen, Tuula Vasankari, Jussi Koivunen

Journal of Medical Internet Research · 2026

DOI: 10.2196/81687 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Internet Research, 2026. Verfasst von Antti Kurtti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Oulu University Hospital, Kajaanintie 50, Oulu, 90029, Finland, 358 504182666, 358 83156449. Hauptthemen laut MEDLINE: Quality of Life, Smoking Cessation, Lung Neoplasms, Mobile Applications. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer screening with low-dose computed tomography (LDCT) among heavy smokers can decrease lung cancer mortality. Smoking cessation intervention is recommended within the screening program; however, the methods for smoking cessation in the LDCT screening context are not well established. We have previously shown that a novel smartphone app can increase the chance for smoking cessation along with lung cancer screening. The effects of lung cancer screening, smoking cessation, and the use of smartphone apps on health-related quality of life (HRQoL) are widely unknown.

Objective

This study aims to investigate the effect of lung cancer screening, smoking cessation, and the use of smoking cessation app on HRQoL, an exploratory end point of the low-dose computed tomography screening for lung cancer combined to different smoking cessation methods in Finland (LDCT-SC-FI) study.

Methods

This study was conducted as a part of the LDCT-SC-FI (NCT05630950), which was a randomized controlled trial investigating different smoking cessation methods in participants undergoing lung cancer screening with LDCT. The main inclusion criteria included an age of 50‐74 years, a marked smoking history (smoked ≥15 cigarettes per day for ≥25 years or smoked ≥10 cigarettes per day for ≥30 years), an active smoking status, and access to a smartphone. The recruitment was carried out by newspaper and internet advertisements and informing relevant health care units at hospital districts. The study participants (n=200), all at Oulu University Hospital, were randomized in 1:1 fashion to a yearly LDCT with standard smoking cessation (written material) or a stand-alone smartphone app–based cessation. HRQoL, an exploratory study end point, was assessed at baseline and at 1 year with Quality of Life Questionnaire Core 30 (QLQ-C30) and EQ-5D.

Results

In total, 199 and 186 individuals had both questionnaires completed at baseline and at 1 year, respectively. We did not detect a change in HRQoL between the time points using QLQ-C30 global health status score or EQ-5D index score. Smoking cessation at 1-year time did not affect QLQ-C30 global health status or EQ-5D. We observed improved quality of life scores by EQ-5D at 1 year (control: mean 0.720, SD 0.197 vs app: mean 0.799, SD 0.197; improved in 17/93, 18% of controls vs 29/93, 31% in app arm), while there was no difference in means at baseline. Smartphone app arm reported reduced pain (EQ-5D effect size [ES] 0.049, 95% CI 0.006‐0.12; P =.01; adjusted ES 0.026; P =.007; QLQ-C30 ES 0.076, 95% CI 0.02‐0.16; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeSmoking CessationLung NeoplasmsMobile ApplicationsSmartphoneEarly Detection of CancerHumansMiddle AgedMaleFemaleAgedFinlandTomography, X-Ray ComputedSmokers

Stichwörter der Autor:innen

health-related quality of lifelow-dose computed tomographylung cancer screeningmobile appsmoking cessation

Autor:innen und Institutionen

  • Cancer Center, Oulu University Hospital, Kajaanintie 50, Oulu, 90029, Finland, 358 504182666, 358 83156449.
  • Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Medical Research Center Oulu, Oulu, Finland.
  • Research Unit of Biomedicine and Internal Medicine, University of Oulu, Oulu, Finland.
  • Department of Oncology and Radiotherapy, Vaasa Central Hospital, Vaasa, Finland.
  • Faculty of Medicine, University of Turku, Turku, Southwest Finland, Finland.

Zitieren

APA

Kurtti, A., Iivanainen, S., Kaarteenaho, R., Andersen, H., Jekunen, A., Vasankari, T., & Koivunen, J. (2026). Effect of Lung Cancer Screening, Smoking Cessation, and Cessation Smartphone App to Health-Related Quality of Life Among Heavy Smokers: Randomized Controlled Trial. Journal of Medical Internet Research. https://doi.org/10.2196/81687

Vancouver

Kurtti A, Iivanainen S, Kaarteenaho R, Andersen H, Jekunen A, Vasankari T, et al. Effect of Lung Cancer Screening, Smoking Cessation, and Cessation Smartphone App to Health-Related Quality of Life Among Heavy Smokers: Randomized Controlled Trial. Journal of Medical Internet Research. 2026. doi:10.2196/81687

BibTeX
@article{Kurtti2026,
  author = {Kurtti, Antti and Iivanainen, Sanna and Kaarteenaho, Riitta and Andersen, Heidi and Jekunen, Antti and Vasankari, Tuula and Koivunen, Jussi},
  title = {Effect of Lung Cancer Screening, Smoking Cessation, and Cessation Smartphone App to Health-Related Quality of Life Among Heavy Smokers: Randomized Controlled Trial},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  doi = {10.2196/81687}
}
Kostenlos starten →